nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2A6—esophageal cancer	0.649	1	CbGaD
Bupropion—CYP2C9—Capecitabine—esophageal cancer	0.02	0.407	CbGbCtD
Bupropion—CYP2B6—Cisplatin—esophageal cancer	0.0191	0.388	CbGbCtD
Bupropion—CYP2C9—Cisplatin—esophageal cancer	0.0101	0.205	CbGbCtD
Bupropion—Lymphadenopathy—Methotrexate—esophageal cancer	0.000313	0.00185	CcSEcCtD
Bupropion—Flushing—Cisplatin—esophageal cancer	0.000312	0.00185	CcSEcCtD
Bupropion—Cardiac disorder—Cisplatin—esophageal cancer	0.000312	0.00185	CcSEcCtD
Bupropion—Abdominal distension—Capecitabine—esophageal cancer	0.000312	0.00185	CcSEcCtD
Bupropion—Asthma—Capecitabine—esophageal cancer	0.00031	0.00183	CcSEcCtD
Bupropion—Influenza—Capecitabine—esophageal cancer	0.00031	0.00183	CcSEcCtD
Bupropion—Dysphagia—Capecitabine—esophageal cancer	0.00031	0.00183	CcSEcCtD
Bupropion—Bronchospasm—Capecitabine—esophageal cancer	0.000305	0.0018	CcSEcCtD
Bupropion—Photosensitivity—Methotrexate—esophageal cancer	0.000304	0.0018	CcSEcCtD
Bupropion—Polyuria—Methotrexate—esophageal cancer	0.000304	0.0018	CcSEcCtD
Bupropion—Immune system disorder—Cisplatin—esophageal cancer	0.000304	0.0018	CcSEcCtD
Bupropion—Mediastinal disorder—Cisplatin—esophageal cancer	0.000303	0.0018	CcSEcCtD
Bupropion—Sweating increased—Capecitabine—esophageal cancer	0.000302	0.00179	CcSEcCtD
Bupropion—Arrhythmia—Cisplatin—esophageal cancer	0.000301	0.00178	CcSEcCtD
Bupropion—Bronchitis—Capecitabine—esophageal cancer	0.000298	0.00176	CcSEcCtD
Bupropion—Alopecia—Cisplatin—esophageal cancer	0.000297	0.00176	CcSEcCtD
Bupropion—Abdominal discomfort—Capecitabine—esophageal cancer	0.000297	0.00176	CcSEcCtD
Bupropion—Pancytopenia—Capecitabine—esophageal cancer	0.000294	0.00174	CcSEcCtD
Bupropion—Malnutrition—Cisplatin—esophageal cancer	0.000293	0.00173	CcSEcCtD
Bupropion—Dysuria—Capecitabine—esophageal cancer	0.00029	0.00172	CcSEcCtD
Bupropion—Flatulence—Cisplatin—esophageal cancer	0.000289	0.00171	CcSEcCtD
Bupropion—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000288	0.00171	CcSEcCtD
Bupropion—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000283	0.00167	CcSEcCtD
Bupropion—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000283	0.00167	CcSEcCtD
Bupropion—Weight increased—Capecitabine—esophageal cancer	0.000282	0.00167	CcSEcCtD
Bupropion—Visual disturbance—Methotrexate—esophageal cancer	0.000282	0.00167	CcSEcCtD
Bupropion—Muscle spasms—Cisplatin—esophageal cancer	0.000282	0.00167	CcSEcCtD
Bupropion—Weight decreased—Capecitabine—esophageal cancer	0.00028	0.00166	CcSEcCtD
Bupropion—Hyperglycaemia—Capecitabine—esophageal cancer	0.000279	0.00165	CcSEcCtD
Bupropion—Pneumonia—Capecitabine—esophageal cancer	0.000278	0.00165	CcSEcCtD
Bupropion—Infestation—Capecitabine—esophageal cancer	0.000276	0.00164	CcSEcCtD
Bupropion—Infestation NOS—Capecitabine—esophageal cancer	0.000276	0.00164	CcSEcCtD
Bupropion—Vision blurred—Cisplatin—esophageal cancer	0.000276	0.00163	CcSEcCtD
Bupropion—Tremor—Cisplatin—esophageal cancer	0.000274	0.00162	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000274	0.00162	CcSEcCtD
Bupropion—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000272	0.00161	CcSEcCtD
Bupropion—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000272	0.00161	CcSEcCtD
Bupropion—Lethargy—Methotrexate—esophageal cancer	0.000272	0.00161	CcSEcCtD
Bupropion—Ill-defined disorder—Cisplatin—esophageal cancer	0.000272	0.00161	CcSEcCtD
Bupropion—Myocardial infarction—Capecitabine—esophageal cancer	0.000271	0.0016	CcSEcCtD
Bupropion—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000271	0.0016	CcSEcCtD
Bupropion—Anaemia—Cisplatin—esophageal cancer	0.000271	0.0016	CcSEcCtD
Bupropion—Stomatitis—Capecitabine—esophageal cancer	0.000269	0.00159	CcSEcCtD
Bupropion—Jaundice—Capecitabine—esophageal cancer	0.000269	0.00159	CcSEcCtD
Bupropion—Conjunctivitis—Capecitabine—esophageal cancer	0.000269	0.00159	CcSEcCtD
Bupropion—Urinary tract infection—Capecitabine—esophageal cancer	0.000269	0.00159	CcSEcCtD
Bupropion—Osteoarthritis—Methotrexate—esophageal cancer	0.000267	0.00158	CcSEcCtD
Bupropion—Malaise—Cisplatin—esophageal cancer	0.000264	0.00156	CcSEcCtD
Bupropion—Leukopenia—Cisplatin—esophageal cancer	0.000262	0.00155	CcSEcCtD
Bupropion—Epistaxis—Capecitabine—esophageal cancer	0.000261	0.00154	CcSEcCtD
Bupropion—Irritability—Methotrexate—esophageal cancer	0.000255	0.00151	CcSEcCtD
Bupropion—Convulsion—Cisplatin—esophageal cancer	0.000254	0.0015	CcSEcCtD
Bupropion—Mood swings—Methotrexate—esophageal cancer	0.000253	0.0015	CcSEcCtD
Bupropion—Ataxia—Methotrexate—esophageal cancer	0.000251	0.00149	CcSEcCtD
Bupropion—Myalgia—Cisplatin—esophageal cancer	0.000249	0.00148	CcSEcCtD
Bupropion—Haemoglobin—Capecitabine—esophageal cancer	0.000249	0.00148	CcSEcCtD
Bupropion—Rhinitis—Capecitabine—esophageal cancer	0.000249	0.00147	CcSEcCtD
Bupropion—Anxiety—Cisplatin—esophageal cancer	0.000248	0.00147	CcSEcCtD
Bupropion—Haemorrhage—Capecitabine—esophageal cancer	0.000248	0.00147	CcSEcCtD
Bupropion—Hepatitis—Capecitabine—esophageal cancer	0.000248	0.00147	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000248	0.00147	CcSEcCtD
Bupropion—Hypoaesthesia—Capecitabine—esophageal cancer	0.000247	0.00146	CcSEcCtD
Bupropion—Discomfort—Cisplatin—esophageal cancer	0.000246	0.00146	CcSEcCtD
Bupropion—Pharyngitis—Capecitabine—esophageal cancer	0.000246	0.00146	CcSEcCtD
Bupropion—Urinary tract disorder—Capecitabine—esophageal cancer	0.000245	0.00145	CcSEcCtD
Bupropion—Oedema peripheral—Capecitabine—esophageal cancer	0.000244	0.00145	CcSEcCtD
Bupropion—Connective tissue disorder—Capecitabine—esophageal cancer	0.000244	0.00144	CcSEcCtD
Bupropion—Urethral disorder—Capecitabine—esophageal cancer	0.000243	0.00144	CcSEcCtD
Bupropion—Breast disorder—Methotrexate—esophageal cancer	0.000241	0.00143	CcSEcCtD
Bupropion—Anaphylactic shock—Cisplatin—esophageal cancer	0.000239	0.00142	CcSEcCtD
Bupropion—Oedema—Cisplatin—esophageal cancer	0.000239	0.00142	CcSEcCtD
Bupropion—Visual impairment—Capecitabine—esophageal cancer	0.000239	0.00142	CcSEcCtD
Bupropion—Infection—Cisplatin—esophageal cancer	0.000237	0.00141	CcSEcCtD
Bupropion—Erythema multiforme—Capecitabine—esophageal cancer	0.000234	0.00139	CcSEcCtD
Bupropion—Nervous system disorder—Cisplatin—esophageal cancer	0.000234	0.00139	CcSEcCtD
Bupropion—Thrombocytopenia—Cisplatin—esophageal cancer	0.000234	0.00139	CcSEcCtD
Bupropion—Tachycardia—Cisplatin—esophageal cancer	0.000233	0.00138	CcSEcCtD
Bupropion—Skin disorder—Cisplatin—esophageal cancer	0.000232	0.00137	CcSEcCtD
Bupropion—Eye disorder—Capecitabine—esophageal cancer	0.000232	0.00137	CcSEcCtD
Bupropion—Tinnitus—Capecitabine—esophageal cancer	0.000231	0.00137	CcSEcCtD
Bupropion—Hyperhidrosis—Cisplatin—esophageal cancer	0.000231	0.00137	CcSEcCtD
Bupropion—Asthma—Methotrexate—esophageal cancer	0.000231	0.00137	CcSEcCtD
Bupropion—Flushing—Capecitabine—esophageal cancer	0.00023	0.00136	CcSEcCtD
Bupropion—Cardiac disorder—Capecitabine—esophageal cancer	0.00023	0.00136	CcSEcCtD
Bupropion—Anorexia—Cisplatin—esophageal cancer	0.000228	0.00135	CcSEcCtD
Bupropion—Pancreatitis—Methotrexate—esophageal cancer	0.000226	0.00134	CcSEcCtD
Bupropion—Angiopathy—Capecitabine—esophageal cancer	0.000225	0.00133	CcSEcCtD
Bupropion—Immune system disorder—Capecitabine—esophageal cancer	0.000224	0.00133	CcSEcCtD
Bupropion—Mediastinal disorder—Capecitabine—esophageal cancer	0.000223	0.00132	CcSEcCtD
Bupropion—Hypotension—Cisplatin—esophageal cancer	0.000223	0.00132	CcSEcCtD
Bupropion—Chills—Capecitabine—esophageal cancer	0.000223	0.00132	CcSEcCtD
Bupropion—Arrhythmia—Capecitabine—esophageal cancer	0.000222	0.00131	CcSEcCtD
Bupropion—Abdominal discomfort—Methotrexate—esophageal cancer	0.000221	0.00131	CcSEcCtD
Bupropion—Alopecia—Capecitabine—esophageal cancer	0.000219	0.0013	CcSEcCtD
Bupropion—Pancytopenia—Methotrexate—esophageal cancer	0.000219	0.0013	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000218	0.00129	CcSEcCtD
Bupropion—Mental disorder—Capecitabine—esophageal cancer	0.000217	0.00129	CcSEcCtD
Bupropion—Malnutrition—Capecitabine—esophageal cancer	0.000216	0.00128	CcSEcCtD
Bupropion—Dysuria—Methotrexate—esophageal cancer	0.000216	0.00128	CcSEcCtD
Bupropion—Paraesthesia—Cisplatin—esophageal cancer	0.000215	0.00127	CcSEcCtD
Bupropion—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000214	0.00127	CcSEcCtD
Bupropion—Dyspnoea—Cisplatin—esophageal cancer	0.000213	0.00126	CcSEcCtD
Bupropion—Flatulence—Capecitabine—esophageal cancer	0.000213	0.00126	CcSEcCtD
Bupropion—Erectile dysfunction—Methotrexate—esophageal cancer	0.000212	0.00126	CcSEcCtD
Bupropion—Dysgeusia—Capecitabine—esophageal cancer	0.000211	0.00125	CcSEcCtD
Bupropion—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000211	0.00125	CcSEcCtD
Bupropion—Back pain—Capecitabine—esophageal cancer	0.000209	0.00124	CcSEcCtD
Bupropion—Decreased appetite—Cisplatin—esophageal cancer	0.000208	0.00123	CcSEcCtD
Bupropion—Muscle spasms—Capecitabine—esophageal cancer	0.000208	0.00123	CcSEcCtD
Bupropion—Pneumonia—Methotrexate—esophageal cancer	0.000207	0.00122	CcSEcCtD
Bupropion—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000206	0.00122	CcSEcCtD
Bupropion—Infestation NOS—Methotrexate—esophageal cancer	0.000206	0.00122	CcSEcCtD
Bupropion—Infestation—Methotrexate—esophageal cancer	0.000206	0.00122	CcSEcCtD
Bupropion—Pain—Cisplatin—esophageal cancer	0.000204	0.00121	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000204	0.00121	CcSEcCtD
Bupropion—Vision blurred—Capecitabine—esophageal cancer	0.000203	0.0012	CcSEcCtD
Bupropion—Tremor—Capecitabine—esophageal cancer	0.000202	0.0012	CcSEcCtD
Bupropion—Stomatitis—Methotrexate—esophageal cancer	0.0002	0.00119	CcSEcCtD
Bupropion—Ill-defined disorder—Capecitabine—esophageal cancer	0.0002	0.00119	CcSEcCtD
Bupropion—Conjunctivitis—Methotrexate—esophageal cancer	0.0002	0.00118	CcSEcCtD
Bupropion—Anaemia—Capecitabine—esophageal cancer	0.0002	0.00118	CcSEcCtD
Bupropion—Sweating—Methotrexate—esophageal cancer	0.000197	0.00117	CcSEcCtD
Bupropion—Feeling abnormal—Cisplatin—esophageal cancer	0.000197	0.00117	CcSEcCtD
Bupropion—Malaise—Capecitabine—esophageal cancer	0.000195	0.00115	CcSEcCtD
Bupropion—Epistaxis—Methotrexate—esophageal cancer	0.000194	0.00115	CcSEcCtD
Bupropion—Vertigo—Capecitabine—esophageal cancer	0.000194	0.00115	CcSEcCtD
Bupropion—Syncope—Capecitabine—esophageal cancer	0.000194	0.00115	CcSEcCtD
Bupropion—Leukopenia—Capecitabine—esophageal cancer	0.000193	0.00114	CcSEcCtD
Bupropion—Palpitations—Capecitabine—esophageal cancer	0.000191	0.00113	CcSEcCtD
Bupropion—Loss of consciousness—Capecitabine—esophageal cancer	0.00019	0.00112	CcSEcCtD
Bupropion—Body temperature increased—Cisplatin—esophageal cancer	0.000189	0.00112	CcSEcCtD
Bupropion—Cough—Capecitabine—esophageal cancer	0.000188	0.00112	CcSEcCtD
Bupropion—Hypertension—Capecitabine—esophageal cancer	0.000186	0.0011	CcSEcCtD
Bupropion—Haemoglobin—Methotrexate—esophageal cancer	0.000186	0.0011	CcSEcCtD
Bupropion—Hepatitis—Methotrexate—esophageal cancer	0.000185	0.00109	CcSEcCtD
Bupropion—Haemorrhage—Methotrexate—esophageal cancer	0.000185	0.00109	CcSEcCtD
Bupropion—Arthralgia—Capecitabine—esophageal cancer	0.000184	0.00109	CcSEcCtD
Bupropion—Chest pain—Capecitabine—esophageal cancer	0.000184	0.00109	CcSEcCtD
Bupropion—Myalgia—Capecitabine—esophageal cancer	0.000184	0.00109	CcSEcCtD
Bupropion—Pharyngitis—Methotrexate—esophageal cancer	0.000183	0.00108	CcSEcCtD
Bupropion—Anxiety—Capecitabine—esophageal cancer	0.000183	0.00108	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000183	0.00108	CcSEcCtD
Bupropion—Urinary tract disorder—Methotrexate—esophageal cancer	0.000182	0.00108	CcSEcCtD
Bupropion—Discomfort—Capecitabine—esophageal cancer	0.000182	0.00108	CcSEcCtD
Bupropion—Urethral disorder—Methotrexate—esophageal cancer	0.000181	0.00107	CcSEcCtD
Bupropion—Dry mouth—Capecitabine—esophageal cancer	0.00018	0.00106	CcSEcCtD
Bupropion—Visual impairment—Methotrexate—esophageal cancer	0.000178	0.00105	CcSEcCtD
Bupropion—Confusional state—Capecitabine—esophageal cancer	0.000178	0.00105	CcSEcCtD
Bupropion—Oedema—Capecitabine—esophageal cancer	0.000176	0.00104	CcSEcCtD
Bupropion—Hypersensitivity—Cisplatin—esophageal cancer	0.000176	0.00104	CcSEcCtD
Bupropion—Infection—Capecitabine—esophageal cancer	0.000175	0.00104	CcSEcCtD
Bupropion—Erythema multiforme—Methotrexate—esophageal cancer	0.000175	0.00103	CcSEcCtD
Bupropion—Shock—Capecitabine—esophageal cancer	0.000173	0.00103	CcSEcCtD
Bupropion—Nervous system disorder—Capecitabine—esophageal cancer	0.000173	0.00102	CcSEcCtD
Bupropion—Eye disorder—Methotrexate—esophageal cancer	0.000173	0.00102	CcSEcCtD
Bupropion—Thrombocytopenia—Capecitabine—esophageal cancer	0.000172	0.00102	CcSEcCtD
Bupropion—Tinnitus—Methotrexate—esophageal cancer	0.000172	0.00102	CcSEcCtD
Bupropion—Tachycardia—Capecitabine—esophageal cancer	0.000172	0.00102	CcSEcCtD
Bupropion—Asthenia—Cisplatin—esophageal cancer	0.000171	0.00102	CcSEcCtD
Bupropion—Cardiac disorder—Methotrexate—esophageal cancer	0.000171	0.00101	CcSEcCtD
Bupropion—Skin disorder—Capecitabine—esophageal cancer	0.000171	0.00101	CcSEcCtD
Bupropion—Hyperhidrosis—Capecitabine—esophageal cancer	0.00017	0.00101	CcSEcCtD
Bupropion—Anorexia—Capecitabine—esophageal cancer	0.000168	0.000994	CcSEcCtD
Bupropion—Angiopathy—Methotrexate—esophageal cancer	0.000167	0.000992	CcSEcCtD
Bupropion—Immune system disorder—Methotrexate—esophageal cancer	0.000167	0.000987	CcSEcCtD
Bupropion—Mediastinal disorder—Methotrexate—esophageal cancer	0.000166	0.000985	CcSEcCtD
Bupropion—Chills—Methotrexate—esophageal cancer	0.000166	0.000981	CcSEcCtD
Bupropion—Hypotension—Capecitabine—esophageal cancer	0.000165	0.000975	CcSEcCtD
Bupropion—Diarrhoea—Cisplatin—esophageal cancer	0.000164	0.000968	CcSEcCtD
Bupropion—Alopecia—Methotrexate—esophageal cancer	0.000163	0.000966	CcSEcCtD
Bupropion—Mental disorder—Methotrexate—esophageal cancer	0.000162	0.000958	CcSEcCtD
Bupropion—Malnutrition—Methotrexate—esophageal cancer	0.000161	0.000952	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000161	0.00095	CcSEcCtD
Bupropion—Insomnia—Capecitabine—esophageal cancer	0.000159	0.000944	CcSEcCtD
Bupropion—Paraesthesia—Capecitabine—esophageal cancer	0.000158	0.000937	CcSEcCtD
Bupropion—Dysgeusia—Methotrexate—esophageal cancer	0.000157	0.000932	CcSEcCtD
Bupropion—Dyspnoea—Capecitabine—esophageal cancer	0.000157	0.00093	CcSEcCtD
Bupropion—Back pain—Methotrexate—esophageal cancer	0.000155	0.00092	CcSEcCtD
Bupropion—Dyspepsia—Capecitabine—esophageal cancer	0.000155	0.000918	CcSEcCtD
Bupropion—Decreased appetite—Capecitabine—esophageal cancer	0.000153	0.000907	CcSEcCtD
Bupropion—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000152	0.000901	CcSEcCtD
Bupropion—Vomiting—Cisplatin—esophageal cancer	0.000152	0.0009	CcSEcCtD
Bupropion—Fatigue—Capecitabine—esophageal cancer	0.000152	0.000899	CcSEcCtD
Bupropion—Vision blurred—Methotrexate—esophageal cancer	0.000151	0.000897	CcSEcCtD
Bupropion—Rash—Cisplatin—esophageal cancer	0.000151	0.000892	CcSEcCtD
Bupropion—Constipation—Capecitabine—esophageal cancer	0.000151	0.000892	CcSEcCtD
Bupropion—Pain—Capecitabine—esophageal cancer	0.000151	0.000892	CcSEcCtD
Bupropion—Dermatitis—Cisplatin—esophageal cancer	0.000151	0.000892	CcSEcCtD
Bupropion—Ill-defined disorder—Methotrexate—esophageal cancer	0.000149	0.000883	CcSEcCtD
Bupropion—Anaemia—Methotrexate—esophageal cancer	0.000149	0.00088	CcSEcCtD
Bupropion—Feeling abnormal—Capecitabine—esophageal cancer	0.000145	0.00086	CcSEcCtD
Bupropion—Malaise—Methotrexate—esophageal cancer	0.000145	0.000858	CcSEcCtD
Bupropion—Vertigo—Methotrexate—esophageal cancer	0.000144	0.000855	CcSEcCtD
Bupropion—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000144	0.000853	CcSEcCtD
Bupropion—Leukopenia—Methotrexate—esophageal cancer	0.000144	0.000852	CcSEcCtD
Bupropion—Nausea—Cisplatin—esophageal cancer	0.000142	0.000841	CcSEcCtD
Bupropion—Cough—Methotrexate—esophageal cancer	0.00014	0.00083	CcSEcCtD
Bupropion—Urticaria—Capecitabine—esophageal cancer	0.00014	0.000829	CcSEcCtD
Bupropion—Abdominal pain—Capecitabine—esophageal cancer	0.000139	0.000825	CcSEcCtD
Bupropion—Body temperature increased—Capecitabine—esophageal cancer	0.000139	0.000825	CcSEcCtD
Bupropion—Convulsion—Methotrexate—esophageal cancer	0.000139	0.000824	CcSEcCtD
Bupropion—Arthralgia—Methotrexate—esophageal cancer	0.000137	0.00081	CcSEcCtD
Bupropion—Chest pain—Methotrexate—esophageal cancer	0.000137	0.00081	CcSEcCtD
Bupropion—Myalgia—Methotrexate—esophageal cancer	0.000137	0.00081	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000136	0.000805	CcSEcCtD
Bupropion—Discomfort—Methotrexate—esophageal cancer	0.000135	0.0008	CcSEcCtD
Bupropion—Confusional state—Methotrexate—esophageal cancer	0.000132	0.000783	CcSEcCtD
Bupropion—Anaphylactic shock—Methotrexate—esophageal cancer	0.000131	0.000777	CcSEcCtD
Bupropion—Infection—Methotrexate—esophageal cancer	0.00013	0.000772	CcSEcCtD
Bupropion—Hypersensitivity—Capecitabine—esophageal cancer	0.00013	0.000769	CcSEcCtD
Bupropion—Nervous system disorder—Methotrexate—esophageal cancer	0.000129	0.000762	CcSEcCtD
Bupropion—Thrombocytopenia—Methotrexate—esophageal cancer	0.000128	0.00076	CcSEcCtD
Bupropion—Skin disorder—Methotrexate—esophageal cancer	0.000127	0.000754	CcSEcCtD
Bupropion—Hyperhidrosis—Methotrexate—esophageal cancer	0.000127	0.000751	CcSEcCtD
Bupropion—Asthenia—Capecitabine—esophageal cancer	0.000126	0.000748	CcSEcCtD
Bupropion—Anorexia—Methotrexate—esophageal cancer	0.000125	0.00074	CcSEcCtD
Bupropion—Pruritus—Capecitabine—esophageal cancer	0.000125	0.000738	CcSEcCtD
Bupropion—Hypotension—Methotrexate—esophageal cancer	0.000123	0.000726	CcSEcCtD
Bupropion—Diarrhoea—Capecitabine—esophageal cancer	0.000121	0.000714	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000119	0.000708	CcSEcCtD
Bupropion—Insomnia—Methotrexate—esophageal cancer	0.000119	0.000702	CcSEcCtD
Bupropion—Paraesthesia—Methotrexate—esophageal cancer	0.000118	0.000697	CcSEcCtD
Bupropion—Dyspnoea—Methotrexate—esophageal cancer	0.000117	0.000692	CcSEcCtD
Bupropion—Somnolence—Methotrexate—esophageal cancer	0.000117	0.00069	CcSEcCtD
Bupropion—Dizziness—Capecitabine—esophageal cancer	0.000117	0.00069	CcSEcCtD
Bupropion—Dyspepsia—Methotrexate—esophageal cancer	0.000115	0.000684	CcSEcCtD
Bupropion—Decreased appetite—Methotrexate—esophageal cancer	0.000114	0.000675	CcSEcCtD
Bupropion—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000113	0.00067	CcSEcCtD
Bupropion—Fatigue—Methotrexate—esophageal cancer	0.000113	0.00067	CcSEcCtD
Bupropion—Pain—Methotrexate—esophageal cancer	0.000112	0.000664	CcSEcCtD
Bupropion—Vomiting—Capecitabine—esophageal cancer	0.000112	0.000663	CcSEcCtD
Bupropion—Rash—Capecitabine—esophageal cancer	0.000111	0.000658	CcSEcCtD
Bupropion—Dermatitis—Capecitabine—esophageal cancer	0.000111	0.000657	CcSEcCtD
Bupropion—Headache—Capecitabine—esophageal cancer	0.00011	0.000654	CcSEcCtD
Bupropion—Feeling abnormal—Methotrexate—esophageal cancer	0.000108	0.00064	CcSEcCtD
Bupropion—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000107	0.000635	CcSEcCtD
Bupropion—Nausea—Capecitabine—esophageal cancer	0.000105	0.00062	CcSEcCtD
Bupropion—Urticaria—Methotrexate—esophageal cancer	0.000104	0.000617	CcSEcCtD
Bupropion—Body temperature increased—Methotrexate—esophageal cancer	0.000104	0.000614	CcSEcCtD
Bupropion—Abdominal pain—Methotrexate—esophageal cancer	0.000104	0.000614	CcSEcCtD
Bupropion—Hypersensitivity—Methotrexate—esophageal cancer	9.66e-05	0.000572	CcSEcCtD
Bupropion—Asthenia—Methotrexate—esophageal cancer	9.41e-05	0.000557	CcSEcCtD
Bupropion—Pruritus—Methotrexate—esophageal cancer	9.28e-05	0.000549	CcSEcCtD
Bupropion—Diarrhoea—Methotrexate—esophageal cancer	8.97e-05	0.000531	CcSEcCtD
Bupropion—Dizziness—Methotrexate—esophageal cancer	8.67e-05	0.000514	CcSEcCtD
Bupropion—Vomiting—Methotrexate—esophageal cancer	8.34e-05	0.000494	CcSEcCtD
Bupropion—Rash—Methotrexate—esophageal cancer	8.27e-05	0.00049	CcSEcCtD
Bupropion—Dermatitis—Methotrexate—esophageal cancer	8.26e-05	0.000489	CcSEcCtD
Bupropion—Headache—Methotrexate—esophageal cancer	8.22e-05	0.000487	CcSEcCtD
Bupropion—Nausea—Methotrexate—esophageal cancer	7.79e-05	0.000461	CcSEcCtD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.16e-05	0.000237	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CA2—esophageal cancer	3.14e-05	0.000236	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ALDOB—esophageal cancer	3.1e-05	0.000233	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.07e-05	0.00023	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ADH1B—esophageal cancer	3.02e-05	0.000227	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GAPDH—esophageal cancer	2.99e-05	0.000224	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CRABP1—esophageal cancer	2.96e-05	0.000222	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ADH1B—esophageal cancer	2.96e-05	0.000222	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.94e-05	0.000221	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PLCE1—esophageal cancer	2.92e-05	0.000219	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ADH7—esophageal cancer	2.92e-05	0.000219	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—TYMP—esophageal cancer	2.89e-05	0.000217	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.88e-05	0.000217	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—TYMP—esophageal cancer	2.83e-05	0.000213	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—SLC10A2—esophageal cancer	2.82e-05	0.000212	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CA1—esophageal cancer	2.82e-05	0.000212	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GNG7—esophageal cancer	2.82e-05	0.000212	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.81e-05	0.000211	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP26A1—esophageal cancer	2.81e-05	0.000211	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—BLVRB—esophageal cancer	2.81e-05	0.000211	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SLC52A3—esophageal cancer	2.81e-05	0.000211	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CA1—esophageal cancer	2.79e-05	0.00021	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—SLC10A2—esophageal cancer	2.79e-05	0.00021	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP26A1—esophageal cancer	2.75e-05	0.000207	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ALOX15—esophageal cancer	2.74e-05	0.000206	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ALOX15—esophageal cancer	2.68e-05	0.000201	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ALDH2—esophageal cancer	2.64e-05	0.000198	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTO1—esophageal cancer	2.61e-05	0.000196	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—TPI1—esophageal cancer	2.61e-05	0.000196	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CA2—esophageal cancer	2.58e-05	0.000194	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ADH1B—esophageal cancer	2.56e-05	0.000192	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—TPI1—esophageal cancer	2.56e-05	0.000192	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTO1—esophageal cancer	2.56e-05	0.000192	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CA2—esophageal cancer	2.55e-05	0.000192	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTT1—esophageal cancer	2.51e-05	0.000189	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.51e-05	0.000189	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ALDOB—esophageal cancer	2.5e-05	0.000188	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.5e-05	0.000188	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ALDOB—esophageal cancer	2.45e-05	0.000184	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—TYMP—esophageal cancer	2.45e-05	0.000184	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GAPDH—esophageal cancer	2.41e-05	0.000181	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ADH7—esophageal cancer	2.4e-05	0.00018	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PLCE1—esophageal cancer	2.4e-05	0.00018	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CRABP1—esophageal cancer	2.39e-05	0.000179	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CA1—esophageal cancer	2.39e-05	0.000179	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.39e-05	0.000179	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP26A1—esophageal cancer	2.38e-05	0.000179	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.38e-05	0.000178	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ADH7—esophageal cancer	2.38e-05	0.000178	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GAPDH—esophageal cancer	2.36e-05	0.000177	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ENO1—esophageal cancer	2.35e-05	0.000177	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTGS1—esophageal cancer	2.35e-05	0.000177	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.35e-05	0.000176	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CRABP1—esophageal cancer	2.34e-05	0.000176	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ALOX15—esophageal cancer	2.32e-05	0.000174	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PSME1—esophageal cancer	2.32e-05	0.000174	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PSME2—esophageal cancer	2.32e-05	0.000174	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GNG7—esophageal cancer	2.27e-05	0.000171	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GNG7—esophageal cancer	2.23e-05	0.000167	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—TPI1—esophageal cancer	2.21e-05	0.000166	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTO1—esophageal cancer	2.21e-05	0.000166	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CA2—esophageal cancer	2.18e-05	0.000164	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.17e-05	0.000163	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.17e-05	0.000163	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.13e-05	0.00016	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ALDH2—esophageal cancer	2.13e-05	0.00016	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ALDOB—esophageal cancer	2.12e-05	0.000159	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.1e-05	0.000158	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ALDH2—esophageal cancer	2.09e-05	0.000157	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.08e-05	0.000156	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.04e-05	0.000153	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ADH7—esophageal cancer	2.03e-05	0.000152	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.03e-05	0.000152	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTT1—esophageal cancer	2.03e-05	0.000152	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CRABP1—esophageal cancer	2.02e-05	0.000152	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—TYMP—esophageal cancer	2.01e-05	0.000151	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.01e-05	0.000151	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP2A6—esophageal cancer	2e-05	0.00015	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP1B1—esophageal cancer	2e-05	0.00015	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—TYMP—esophageal cancer	1.99e-05	0.00015	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTT1—esophageal cancer	1.98e-05	0.000149	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP2A6—esophageal cancer	1.96e-05	0.000147	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.95e-05	0.000147	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.94e-05	0.000145	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GNG7—esophageal cancer	1.92e-05	0.000145	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.9e-05	0.000143	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.9e-05	0.000143	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ENO1—esophageal cancer	1.9e-05	0.000143	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.89e-05	0.000142	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP19A1—esophageal cancer	1.88e-05	0.000141	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PSME1—esophageal cancer	1.87e-05	0.000141	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PSME2—esophageal cancer	1.87e-05	0.000141	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ENO1—esophageal cancer	1.86e-05	0.00014	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTGS1—esophageal cancer	1.86e-05	0.00014	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CA1—esophageal cancer	1.84e-05	0.000138	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.84e-05	0.000138	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PSME2—esophageal cancer	1.83e-05	0.000138	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PSME1—esophageal cancer	1.83e-05	0.000138	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—TPI1—esophageal cancer	1.82e-05	0.000136	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.82e-05	0.000136	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.8e-05	0.000135	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.8e-05	0.000135	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—TPI1—esophageal cancer	1.8e-05	0.000135	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.78e-05	0.000134	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.74e-05	0.000131	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.73e-05	0.00013	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—HMOX1—esophageal cancer	1.72e-05	0.000129	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.71e-05	0.000129	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—TYMP—esophageal cancer	1.7e-05	0.000128	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.7e-05	0.000127	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.69e-05	0.000127	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CA2—esophageal cancer	1.68e-05	0.000127	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.68e-05	0.000126	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.66e-05	0.000125	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.66e-05	0.000125	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.65e-05	0.000124	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.65e-05	0.000124	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.65e-05	0.000124	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.61e-05	0.000121	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.61e-05	0.000121	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.61e-05	0.000121	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ENO1—esophageal cancer	1.61e-05	0.000121	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PSME1—esophageal cancer	1.58e-05	0.000119	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PSME2—esophageal cancer	1.58e-05	0.000119	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP1B1—esophageal cancer	1.58e-05	0.000119	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GNG7—esophageal cancer	1.58e-05	0.000119	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ADH7—esophageal cancer	1.57e-05	0.000118	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.57e-05	0.000118	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GNG7—esophageal cancer	1.57e-05	0.000118	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.54e-05	0.000116	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—TPI1—esophageal cancer	1.54e-05	0.000116	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.52e-05	0.000114	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.49e-05	0.000112	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.48e-05	0.000111	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.47e-05	0.000111	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.47e-05	0.00011	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.42e-05	0.000107	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.41e-05	0.000106	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.41e-05	0.000106	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.4e-05	0.000105	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.39e-05	0.000105	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.38e-05	0.000104	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.38e-05	0.000104	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.38e-05	0.000104	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.37e-05	0.000103	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.37e-05	0.000103	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.37e-05	0.000103	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.36e-05	0.000102	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GNG7—esophageal cancer	1.34e-05	0.000101	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.33e-05	9.98e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.32e-05	9.91e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ENO1—esophageal cancer	1.32e-05	9.91e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—TYMP—esophageal cancer	1.31e-05	9.86e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ENO1—esophageal cancer	1.31e-05	9.82e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.31e-05	9.82e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.3e-05	9.78e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PSME1—esophageal cancer	1.3e-05	9.77e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PSME2—esophageal cancer	1.3e-05	9.77e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PSME2—esophageal cancer	1.29e-05	9.68e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PSME1—esophageal cancer	1.29e-05	9.68e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.28e-05	9.65e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.28e-05	9.59e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.25e-05	9.42e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.24e-05	9.35e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.19e-05	8.96e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.19e-05	8.92e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—TPI1—esophageal cancer	1.19e-05	8.92e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.18e-05	8.86e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.17e-05	8.82e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.17e-05	8.81e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.15e-05	8.64e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.14e-05	8.55e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.13e-05	8.45e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.13e-05	8.45e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.12e-05	8.43e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ENO1—esophageal cancer	1.12e-05	8.4e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.12e-05	8.4e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.11e-05	8.35e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PSME1—esophageal cancer	1.1e-05	8.27e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PSME2—esophageal cancer	1.1e-05	8.27e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CREBBP—esophageal cancer	1.1e-05	8.27e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.1e-05	8.23e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.09e-05	8.16e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.05e-05	7.92e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.05e-05	7.85e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GNG7—esophageal cancer	1.03e-05	7.76e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—NOS3—esophageal cancer	9.86e-06	7.4e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ALDH2—esophageal cancer	9.68e-06	7.27e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—HMOX1—esophageal cancer	9.62e-06	7.23e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.62e-06	7.22e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—HMOX1—esophageal cancer	9.54e-06	7.17e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP1B1—esophageal cancer	9.5e-06	7.14e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.36e-06	7.03e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ABCB1—esophageal cancer	9.24e-06	6.94e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTT1—esophageal cancer	9.21e-06	6.91e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ABCB1—esophageal cancer	9.16e-06	6.88e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP2A6—esophageal cancer	9.1e-06	6.84e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTGS2—esophageal cancer	9.02e-06	6.77e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP19A1—esophageal cancer	8.94e-06	6.71e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CREBBP—esophageal cancer	8.88e-06	6.67e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CREBBP—esophageal cancer	8.7e-06	6.54e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ENO1—esophageal cancer	8.63e-06	6.48e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTGS1—esophageal cancer	8.63e-06	6.48e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.51e-06	6.39e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PSME2—esophageal cancer	8.5e-06	6.38e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PSME1—esophageal cancer	8.5e-06	6.38e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—HMOX1—esophageal cancer	8.15e-06	6.12e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8e-06	6.01e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NOS3—esophageal cancer	7.95e-06	5.97e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ABCB1—esophageal cancer	7.83e-06	5.88e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NOS3—esophageal cancer	7.79e-06	5.85e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CREBBP—esophageal cancer	7.52e-06	5.65e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—EP300—esophageal cancer	7.5e-06	5.63e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7.33e-06	5.51e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTGS2—esophageal cancer	7.27e-06	5.46e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTGS2—esophageal cancer	7.12e-06	5.35e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.92e-06	5.2e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.9e-06	5.18e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NOS3—esophageal cancer	6.73e-06	5.06e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—HMOX1—esophageal cancer	6.29e-06	4.73e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CREBBP—esophageal cancer	6.17e-06	4.64e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTGS2—esophageal cancer	6.16e-06	4.63e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CREBBP—esophageal cancer	6.12e-06	4.6e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—EP300—esophageal cancer	6.05e-06	4.54e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ABCB1—esophageal cancer	6.04e-06	4.54e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—EP300—esophageal cancer	5.93e-06	4.45e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.92e-06	4.44e-05	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CA—esophageal cancer	5.55e-06	4.17e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NOS3—esophageal cancer	5.53e-06	4.15e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NOS3—esophageal cancer	5.48e-06	4.12e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CREBBP—esophageal cancer	5.23e-06	3.93e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—EP300—esophageal cancer	5.12e-06	3.85e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTGS2—esophageal cancer	5.06e-06	3.8e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTGS2—esophageal cancer	5.01e-06	3.77e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NOS3—esophageal cancer	4.68e-06	3.52e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CA—esophageal cancer	4.48e-06	3.36e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CA—esophageal cancer	4.38e-06	3.29e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTGS2—esophageal cancer	4.28e-06	3.22e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—EP300—esophageal cancer	4.2e-06	3.16e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—EP300—esophageal cancer	4.17e-06	3.13e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.04e-06	3.03e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3.79e-06	2.85e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NOS3—esophageal cancer	3.61e-06	2.71e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—EP300—esophageal cancer	3.56e-06	2.68e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.31e-06	2.48e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.11e-06	2.34e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.08e-06	2.32e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—EP300—esophageal cancer	2.75e-06	2.07e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.64e-06	1.98e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.03e-06	1.53e-05	CbGpPWpGaD
